Literature DB >> 31682923

In vitro production of synthetic viral RNAs and their delivery into mammalian cells and the application of viral RNAs in the study of innate interferon responses.

Miao Jiang1, Pamela Österlund2, Minna M Poranen3, Ilkka Julkunen4.   

Abstract

Mammalian cells express different types of RNA molecules that can be classified as protein coding RNAs (mRNA) and non-coding RNAs (ncRNAs) the latter of which have housekeeping and regulatory functions in cells. Cellular RNAs are not recognized by cellular pattern recognition receptors (PRRs) and innate immunity is not activated. RNA viruses encode and express RNA molecules that usually differ from cell-specific RNAs and they include for instance 5'capped and 5'mono- and triphosphorylated RNAs, small viral RNAs and viral RNA-protein complexes called vRNPs. These molecules are recognized by certain members of Toll-like receptor (TLR) and RIG-I-like receptor (RLR) families leading to activation of innate immune responses and the production of antiviral cytokines, such as type I and type III interferons (IFNs). Virus-specific ssRNA and dsRNA molecules that mimic the viral genomic RNAs or their replication intermediates can efficiently be produced by bacteriophage T7 DNA-dependent RNA polymerase and bacteriophage phi6 RNA-dependent RNA polymerase, respectively. These molecules can then be delivered into mammalian cells and the mechanisms of activation of innate immune responses can be studied. In addition, synthetic viral dsRNAs can be processed to small interfering RNAs (siRNAs) by a Dicer enzyme to produce a swarm of antiviral siRNAs. Here we describe the biology of RNAs, their in vitro production and delivery into mammalian cells as well as how these molecules can be used to inhibit virus replication and to study the mechanisms of activation of the innate immune system.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dendritic cells (DCs); DsiRNA; In vitro RNA production; Innate immunity; Interferon (IFN) response; RNA; RNA delivery; Virus

Year:  2019        PMID: 31682923     DOI: 10.1016/j.ymeth.2019.10.013

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  3 in total

1.  Editorial for "Methods to characterize virus small RNAs and RNA structures".

Authors:  Gary Brewer; Mei-Ling Li; Blanton S Tolbert
Journal:  Methods       Date:  2020-10-16       Impact factor: 3.608

Review 2.  Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic.

Authors:  Xianghui Li; Yabo Zhang; Libing He; Jiangzhe Si; Shuai Qiu; Yuhua He; Jiacun Wei; Zhili Wang; Longxiang Xie; Yanzhang Li; Tieshan Teng
Journal:  Int J Biol Sci       Date:  2022-02-14       Impact factor: 10.750

3.  Filovirus VP24 Proteins Differentially Regulate RIG-I and MDA5-Dependent Type I and III Interferon Promoter Activation.

Authors:  Felix B He; Hira Khan; Moona Huttunen; Pekka Kolehmainen; Krister Melén; Sari Maljanen; Mengmeng Qu; Miao Jiang; Laura Kakkola; Ilkka Julkunen
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.